STAT+: Dems say RFK Jr. has a pattern of failing to answer their questions
Stat News • 4/27/2026 – 4/28/2026
Summary
Democrats have expressed frustration with RFK Jr. for failing to answer their questions. Kennedy broke his pledge to share a controversial contract, which has contributed to their dissatisfaction with the health secretary.
Advertisement
Lindy Score Breakdown (V4.2)
17h
Age
1
Sources
from cluster
3
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier96% (0.5^3/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study
Stat News • 1 day ago
STAT+: Astellas retries XLMTM gene therapy after deaths
Stat News • 1 day ago
STAT+: Doctor, wife of acting U.S. attorney general, appointed to NIH advisory council
Stat News • 1 day ago
STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial
Stat News • 1 day ago
STAT+: An insider reveals the real goals of prior authorization
Stat News • 1 day ago
STAT+: Eli Lilly enlists AI startup for next-generation gene editors
Stat News • Today
STAT+: Google clinical director says AI can be a ‘bridge’ for people having a mental health crisis
Stat News • Today
STAT+: A giant question looms over GOP’s new Medicaid work requirements
Stat News • Today
STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
Stat News • Today
STAT+: Zap in a cap: How one neurotech startup is using a hat to treat depression
Stat News • 1 day ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about obesity pill trial results, cholesterol guidelines, and more
Stat News • 1+ months
STAT+: As controversial decisions mount, FDA shuns public advisory meetings
Stat News • 1+ months
STAT+: Pharmalittle: We’re reading about TrumpRx expectations, a high-dose version of Wegovy, and more
Stat News • 1+ months
STAT+: Pharmalittle: We’re reading about an FDA plan for ultra-rare drugs, Novo cutting GLP-1 drug prices, and more
Stat News • 2+ months
STAT+: Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pill
Stat News • 1+ months
STAT+: UniQure plans to seek approval for Huntington’s therapy still blocked by FDA
Stat News • 1+ months
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1+ months
STAT+: Medicare chief says TrumpRx is meant to be narrow in scope
Stat News • 1+ months
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1+ months
STAT+: Steve Ubl to step down as CEO of PhRMA
Stat News • 2 weeks ago